FDA Approves Extina(R) For The Treatment Of Seborrheic Dermatitis

July 18th, 2007 posted by kasume
Add comments

FDA Approves Extina(R) For The Treatment Of Seborrheic Dermatitis (Medical News Today)

Stiefel Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its new drug application for Extina(R) (ketoconazole) Foam, 2% for the treatment of seborrheic dermatitis. The approval, which the company received June 12, clears the way for the product to be sold and marketed in the United States. [click link for full article]

technorati tags: